Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 InfectionJinkai Wan, Fei Lan, Chengli Qiu et al.|Cell Reports|2020Cited by 164
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu et al.|Nature Microbiology|2022Cited by 159
Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variantsChunyan Yi, Bing Sun, Xiaoyu Sun et al.|Genome Medicine|2021Cited by 71
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvantsHaitao Liu, Ge Liu, Chenliang Zhou et al.|Vaccine|2021Cited by 32
A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challengeXiangchuan He, Jianqing Xu, Longfei Ding et al.|Emerging Microbes & Infections|2021Cited by 7